Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy.

This publication has 45 references indexed in Scilit:

• The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
  Journal of Clinical Oncology, 2003
• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
  New England Journal of Medicine, 2002
• Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast
  European Journal of Surgical Oncology, 2001
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
  European Journal Of Cancer, 1995
• Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
  European Journal Of Cancer, 1994
• Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast
  Cancer, 1994
• Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or More
  JNCI Journal of the National Cancer Institute, 1990
• Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
  Cancer, 1988
• Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast
  New England Journal of Medicine, 1981